Liquid biopsy assay for real-time monitoring of circulating tumor markers and cells during perioperative periods to assess surgical outcomes and recurrence risk.
Manufactured by
guangzhou biotron technolongy co.,ltd
China
Guangzhou Biotron Technology Co., Ltd. is a Chinese manufacturer of in vitro diagnostic (IVD) products, specializing in molecular diagnostics (multiplex PCR platforms), point-of-care testing (POCT), pathology diagnostics, and tumor liquid biopsy systems. Their product lines include respiratory pathogen detection panels, HPV testing, tuberculosis IGRA assays, and circulating tumor cell (CTC) detection systems. The company also offers CDMO services for diagnostic product development.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Singlera GENOMICS (SHANGHAI) Ltd.
China · 2 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
72 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 102 closest product alternatives
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
HLB PANAGENE Co., Ltd. · South Korea
A liquid biopsy diagnostic test for detection of EGFR mutations in circulating tumor DNA, supporting non-invasive lung cancer monitoring and treatment selection.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products